Company Profile

Cash Flow

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private

BSE1790.85-10.25 (-0.57 %)

PREV CLOSE ( ) 1801.10

OPEN PRICE ( ) 1809.95

BID PRICE (QTY) 1791.00 (7)

OFFER PRICE (QTY) 1795.05 (8)

VOLUME 8143

TODAY'S LOW / HIGH ( )1754.55 1814.55

52 WK LOW / HIGH ( )1035 1909.55

NSE1783.00-20.1 (-1.11 %)

PREV CLOSE( ) 1803.10

OPEN PRICE ( ) 1812.00

BID PRICE (QTY) 1782.90 (34)

OFFER PRICE (QTY) 1783.00 (716)

VOLUME 175448

TODAY'S LOW / HIGH( ) 1753.90 1823.90

52 WK LOW / HIGH ( )1051.05 1910

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

4888.70

4313.40

4046.43

4421.98

3944.97

Adjustment

5480.50

2541.60

1398.39

492.52

440.72

Changes In working Capital

1259.70

-987.40

-1755.36

-299.01

53.27

Cash Flow after changes in Working Capital

11628.90

5867.60

3689.46

4615.49

4438.96

Cash Flow from Operating Activities

10650.10

4860.10

2917.38

3782.64

3753.61

Cash Flow from Investing Activities

-799.70

-18545.20

-9821.01

-3196.10

-3233.58

Cash Flow from Financing Activities

-8813.20

13796.80

6880.25

-446.99

-823.95

Net Cash Inflow / Outflow

1037.20

111.70

-23.38

139.55

-303.92

Opening Cash & Cash Equivalents

942.50

560.20

508.70

369.15

673.07

Cash & Cash Equivalent on Amalgamation / Take over / Merger

17.70

269.60

74.90

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

1997.40

941.50

560.22

508.70

369.15